thiazolidines has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carnero, A; Fernández-Fernández, MC; García-Heredia, JM; Martinez-Pérez, J; Muñoz-Galván, S; Ortiz, MJ; Peinado-Serrano, J; Rivero, M | 1 |
| Beijersbergen, RL; Bernards, R; Brunen, D; de Vries, RC; Lieftink, C | 1 |
2 other study(ies) available for thiazolidines and Local Neoplasm Recurrence
| Article | Year |
|---|---|
PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
Topics: Adult; Aged; Apoptosis; Biomarkers, Pharmacological; Biomarkers, Tumor; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Plasminogen Activator Inhibitor 1; Prognosis; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rectal Neoplasms; Thiazolidines | 2020 |
PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Biphenyl Compounds; Cell Proliferation; CRISPR-Cas Systems; Female; Follow-Up Studies; Humans; Infant; Male; Mice; Mice, Nude; Neoplasm Recurrence, Local; Neuroblastoma; Neurofibromin 1; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Survival Rate; Thiazolidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |